Magrath George 4
4 · Opus Genetics, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Magrath George
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-03-13+330,697→ 929,847 total - Award
Employee Stock Option (right to buy)
2025-03-13+330,697→ 330,697 totalExercise: $0.93Exp: 2035-03-12→ Common Stock (330,697 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.
- [F2]The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.